Brief: S2Medical Announces Outcome From Evaluation Of Epiprotect
Sept 28 (Reuters) - S2Medical AB (publ) S2ME.ST :
* POSITIVE OUTCOME FROM EVALUATION OF EPIPROTECT IN SAUDI
ARABIA
* EXPECTS PURCHASE CODE FOR PRODUCT TO BE PROVIDED
* PURCHASE CODE, EXPECTED TO BE REGISTERED WITHIN 2 MONTHS,
WILL
ALLOW ORDERS THROUGH NATIONAL PURCHASING UNIT
Source text for Eikon: ID:nWkr34Zsm3
Further company coverage: S2ME.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))